Literature DB >> 23879543

Knockdown of ECHS1 protein expression inhibits hepatocellular carcinoma cell proliferation via suppression of Akt activity.

Xiao-san Zhu1, Yi-chen Dai, Zhang-xing Chen, Jun-pei Xie, Wei Zeng, Yuan-yuan Lin, Qiu-hui Tan.   

Abstract

Overexpression of ECHS1 occurs in different cancers, including hepatocellular carcinoma (HCC). ECHS1 is also reported to have an oncogenic activity in various human cancers. This study investigated the effect of ECHS1 knockdown on the regulation of HCC growth. ECHS1 shRNA suppressed the expression of ECHS1 protein in HepG2 cells compared to the negative control vector-transfected HCC cells. ECHS1 knockdown also reduced HCC cell viability and enhanced cisplatin-induced apoptosis in HCC cells. Akt activation and the expression of various cell cycle-related genes were inhibited following ECHS1 knockdown. ECHS1 shRNA suppressed hepatocellular carcinoma growth in tumor xenograft mice. These data demonstrate that ECHS1 may play a role in HCC progression, suggesting that inhibition of ECHS1 expression using ECHS1 shRNA should be further evaluated as a novel target for the control of HCC.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23879543     DOI: 10.1615/critreveukaryotgeneexpr.2013007531

Source DB:  PubMed          Journal:  Crit Rev Eukaryot Gene Expr        ISSN: 1045-4403            Impact factor:   1.807


  8 in total

1.  ComPPI: a cellular compartment-specific database for protein-protein interaction network analysis.

Authors:  Daniel V Veres; Dávid M Gyurkó; Benedek Thaler; Kristóf Z Szalay; Dávid Fazekas; Tamás Korcsmáros; Peter Csermely
Journal:  Nucleic Acids Res       Date:  2014-10-27       Impact factor: 16.971

2.  Expression of enoyl coenzyme A hydratase, short chain, 1, in colorectal cancer and its association with clinicopathological characteristics.

Authors:  Jun-Pei Xie; Xiao-San Zhu; Yi-Chen Dai; Cui Yu; Tao Xie; Zhang-Xing Chen
Journal:  Mol Clin Oncol       Date:  2014-07-09

3.  Combined Therapy Sensitivity Index Based on a 13-Gene Signature Predicts Prognosis for IDH Wild-type and MGMT Promoter Unmethylated Glioblastoma Patients.

Authors:  Ningrong Ye; Nian Jiang; Chengyuan Feng; Feiyifan Wang; Hanwen Zhang; Harrusin Xiao Bai; Li Yang; Yandong Su; Chunhai Huang; Siyi Wanggou; Xuejun Li
Journal:  J Cancer       Date:  2019-08-29       Impact factor: 4.207

4.  Differential mitochondrial proteomic analysis of A549 cells infected with avian influenza virus subtypes H5 and H9.

Authors:  Yuting Yang; Yun Zhang; Changcheng Yang; Fang Fang; Ying Wang; Haiyan Chang; Ze Chen; Ping Chen
Journal:  Virol J       Date:  2021-02-18       Impact factor: 4.099

5.  ECHS1, an interacting protein of LASP1, induces sphingolipid-metabolism imbalance to promote colorectal cancer progression by regulating ceramide glycosylation.

Authors:  Rui Li; Yanyu Hao; Qiuhan Wang; Yuan Meng; Kunhe Wu; Chaoqun Liu; Lijun Xu; Ziguang Liu; Liang Zhao
Journal:  Cell Death Dis       Date:  2021-10-06       Impact factor: 8.469

6.  Genetics of aging, health, and survival: dynamic regulation of human longevity related traits.

Authors:  Anatoliy I Yashin; Deqing Wu; Liubov S Arbeeva; Konstantin G Arbeev; Alexander M Kulminski; Igor Akushevich; Mikhail Kovtun; Irina Culminskaya; Eric Stallard; Miaozhu Li; Svetlana V Ukraintseva
Journal:  Front Genet       Date:  2015-04-13       Impact factor: 4.599

7.  Drug resistance reversed by silencing LIM domain-containing protein 1 expression in colorectal carcinoma.

Authors:  Zhangxing Chen; Xiaosan Zhu; Tao Xie; Junpei Xie; Kong Quo; Xiang Liu
Journal:  Oncol Lett       Date:  2014-05-19       Impact factor: 2.967

8.  Comparative Proteomic Analysis of Advanced Ovarian Cancer Tissue to Identify Potential Biomarkers of Responders and Nonresponders to First-Line Chemotherapy of Carboplatin and Paclitaxel.

Authors:  Urmila Sehrawat; Ruchika Pokhriyal; Ashish Kumar Gupta; Roopa Hariprasad; Mohd Imran Khan; Divya Gupta; Jasmine Naru; Sundararajan Baskar Singh; Ashok Kumar Mohanty; Perumal Vanamail; Lalit Kumar; Sunesh Kumar; Gururao Hariprasad
Journal:  Biomark Cancer       Date:  2016-03-16
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.